| Literature DB >> 25432721 |
Christiana Ossig1, Heinz Reichmann2.
Abstract
The initiation of therapy in Parkinson disease (PD), altering the medication, adding new substances, and switching to alternative therapies throughout the disease is always a matter of debate. In the past, experts in PD have propagated different medication strategies. Even though there is no new medical treatment on the horizon, much has changed in consideration of the known treatments in the early and advanced therapy for PD. Therapeutic regimens have to be adapted and adjusted on a regular basis to accomplish the best medical care for the predominant symptom of the individual patient with PD.Entities:
Keywords: Continuous dopaminergic stimulation; Dopamine agonists; Dyskinesia; Hypokinesia; Levodopa; Parkinson's disease
Mesh:
Substances:
Year: 2015 PMID: 25432721 DOI: 10.1016/j.ncl.2014.09.009
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806